Employees Retirement System of Texas’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-5,508
Closed -$244K – 818
2021
Q3
$244K Hold
5,508
– – ﹤0.01% 766
2021
Q2
$313K Hold
5,508
– – ﹤0.01% 723
2021
Q1
$412K Hold
5,508
– – 0.01% 714
2020
Q4
$476K Hold
5,508
– – 0.01% 621
2020
Q3
$337K Hold
5,508
– – ﹤0.01% 689
2020
Q2
$229K Hold
5,508
– – ﹤0.01% 716
2020
Q1
$158K Hold
5,508
– – ﹤0.01% 735
2019
Q4
$398K Hold
5,508
– – 0.01% 763
2019
Q3
$773K Buy
+5,508
New +$921K 0.01% 764

Other funds holding SAGE

Employees Retirement System of Texas's SAGE Position: Q4 2021 in Review

Employees Retirement System of Texas sold out of Sage Therapeutics (SAGE) in Q4 2021, closing a stake of 5,508 shares — an estimated $244K sold.

Employees Retirement System of Texas first reported a position in SAGE in Q3 2019 and held it in 9 quarters. The position peaked at $773K in Q3 2019. 217 funds tracked by Wall St. Rank hold SAGE as of Q4 2021.

  • Employees Retirement System of Texas reported no remaining Sage Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Employees Retirement System of Texas sold 5,508 Sage Therapeutics shares in Q4 2021, an estimated $244K.
  • Employees Retirement System of Texas first reported a position in Sage Therapeutics in Q3 2019 and held it in 9 quarters.
  • Employees Retirement System of Texas's Sage Therapeutics position peaked at $773K in Q3 2019.
  • 217 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2021.

Based on Employees Retirement System of Texas's 13F filing for Q4 2021, filed 15 Feb 2022.